Science and Medicine

NeoVista, Inc. is developing a novel therapy to treat wet Age-Related Macular Degeneration (AMD) utilizing a Strontium-90 isotope. Listed in this section are articles that will help you understand more about Wet AMD.
- Diagnosed with Age-Related Macular Degeneration
- Symptoms of Macular Degeneration
- What is Wet Macular Degeneration?
... more articles

NeoVista, Inc. is developing an intraocular epiretinal radiation device intended for the treatment of the wet form of Age-Related Macular Degeneration (AMD).
Wet AMD is the leading cause of blindness in the elderly in the US with approximately 200,000 new cases annually and a prevalence of approximately 1.5 million patients.
Visit the NeoVista, Inc. Corporate Overview page to learn more.
